QQQ   431.84 (+0.18%)
AAPL   169.67 (-1.75%)
MSFT   415.79 (+0.52%)
META   501.35 (+0.22%)
GOOGL   154.75 (-0.07%)
AMZN   183.81 (+0.10%)
TSLA   157.14 (-2.69%)
NVDA   877.64 (+2.05%)
AMD   163.53 (+2.00%)
NIO   3.84 (-1.29%)
BABA   69.89 (-1.03%)
T   16.08 (-0.99%)
F   12.17 (-0.49%)
MU   122.06 (+0.57%)
GE   156.46 (+1.80%)
CGC   6.70 (-4.01%)
DIS   113.99 (+0.92%)
AMC   2.78 (+12.55%)
PFE   25.74 (-0.66%)
PYPL   63.71 (+0.31%)
XOM   118.81 (-0.73%)
QQQ   431.84 (+0.18%)
AAPL   169.67 (-1.75%)
MSFT   415.79 (+0.52%)
META   501.35 (+0.22%)
GOOGL   154.75 (-0.07%)
AMZN   183.81 (+0.10%)
TSLA   157.14 (-2.69%)
NVDA   877.64 (+2.05%)
AMD   163.53 (+2.00%)
NIO   3.84 (-1.29%)
BABA   69.89 (-1.03%)
T   16.08 (-0.99%)
F   12.17 (-0.49%)
MU   122.06 (+0.57%)
GE   156.46 (+1.80%)
CGC   6.70 (-4.01%)
DIS   113.99 (+0.92%)
AMC   2.78 (+12.55%)
PFE   25.74 (-0.66%)
PYPL   63.71 (+0.31%)
XOM   118.81 (-0.73%)
QQQ   431.84 (+0.18%)
AAPL   169.67 (-1.75%)
MSFT   415.79 (+0.52%)
META   501.35 (+0.22%)
GOOGL   154.75 (-0.07%)
AMZN   183.81 (+0.10%)
TSLA   157.14 (-2.69%)
NVDA   877.64 (+2.05%)
AMD   163.53 (+2.00%)
NIO   3.84 (-1.29%)
BABA   69.89 (-1.03%)
T   16.08 (-0.99%)
F   12.17 (-0.49%)
MU   122.06 (+0.57%)
GE   156.46 (+1.80%)
CGC   6.70 (-4.01%)
DIS   113.99 (+0.92%)
AMC   2.78 (+12.55%)
PFE   25.74 (-0.66%)
PYPL   63.71 (+0.31%)
XOM   118.81 (-0.73%)
QQQ   431.84 (+0.18%)
AAPL   169.67 (-1.75%)
MSFT   415.79 (+0.52%)
META   501.35 (+0.22%)
GOOGL   154.75 (-0.07%)
AMZN   183.81 (+0.10%)
TSLA   157.14 (-2.69%)
NVDA   877.64 (+2.05%)
AMD   163.53 (+2.00%)
NIO   3.84 (-1.29%)
BABA   69.89 (-1.03%)
T   16.08 (-0.99%)
F   12.17 (-0.49%)
MU   122.06 (+0.57%)
GE   156.46 (+1.80%)
CGC   6.70 (-4.01%)
DIS   113.99 (+0.92%)
AMC   2.78 (+12.55%)
PFE   25.74 (-0.66%)
PYPL   63.71 (+0.31%)
XOM   118.81 (-0.73%)

Soleno Therapeutics (SLNO) SEC Filings & 10K Form

$37.73
-0.79 (-2.05%)
(As of 03:45 PM ET)

Recent Soleno Therapeutics SEC Filings

DateFilerForm TypeView
04/03/2024
8:36 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:37 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:39 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
8:40 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:06 AM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
4:35 PM
JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G/A
02/07/2024
7:01 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G/A
01/30/2024
3:57 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
4:42 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
4:44 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
4:47 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:31 PM
MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:34 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:35 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:36 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:37 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
3:16 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
5:00 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
6:57 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
4:09 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
8:32 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
8:32 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
8:34 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
8:34 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
3:46 PM
Soleno Therapeutics (Subject)
Yen Kristen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
3:53 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
5:17 PM
Soleno Therapeutics (Subject)
Yen Kristen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2023
6:05 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2023
6:21 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
7:41 PM
MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
7:02 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
7:03 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
7:04 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
7:06 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
8:50 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
8:51 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
8:52 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
8:52 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
11:15 PM
Soleno Therapeutics (Filer)
Form EFFECT
10/23/2023
3:20 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
10/20/2023
3:32 PM
Soleno Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
Trump’s “Tax Free” Retirement Strategy (Ad)

Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.

Protect your retirement savings from the inevitable devaluation of the dollar…
10/16/2023
3:30 PM
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
10/12/2023
3:30 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G
10/12/2023
3:05 PM
COMMODORE CAPITAL LP (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G
10/11/2023
3:30 PM
Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SC 13D/A
10/10/2023
3:30 PM
Fairmount Funds Management LLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G
10/06/2023
10:45 AM
JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G
10/05/2023
4:09 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G
10/04/2023
3:30 PM
Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
9:36 AM
Soleno Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
10/02/2023
6:54 PM
Abingworth Bioventures VII LP (Reporting)
Abingworth LLP (Reporting)
Carlyle Genesis UK LLC (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Investment Management LLC (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
Soleno Therapeutics (Issuer)
TC Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
3:51 PM
Soleno Therapeutics (Filer)
Form 424B5
09/28/2023
8:51 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
09/28/2023
4:00 PM
Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2023
2:45 PM
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2023
6:00 AM
Soleno Therapeutics (Subject)
Form FWP
09/28/2023
6:02 AM
Soleno Therapeutics (Subject)
Form FWP
09/27/2023
8:32 PM
Soleno Therapeutics (Filer)
Form S-3MEF
09/27/2023
4:23 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2023
4:26 PM
Soleno Therapeutics (Filer)
Form 424B5
09/26/2023
6:30 AM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2023
3:15 PM
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
08/16/2023
3:12 PM
Pauls Matthew (Reporting)
Soleno Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/16/2023
3:13 PM
Pauls Matthew (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
8:00 AM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
4:25 PM
Soleno Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/02/2023
11:15 PM
Soleno Therapeutics (Filer)
Form EFFECT
07/21/2023
3:10 PM
Soleno Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/10/2023
3:06 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
7:13 PM
Soleno Therapeutics (Issuer)
Volck Birgitte (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2023
4:41 PM
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2023
4:00 PM
Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SC 13D
05/30/2023
3:15 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
05/26/2023
5:26 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
5:27 PM
Harris William G (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
5:28 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
5:28 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
5:29 PM
MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
5:30 PM
Melincoff Gwen A (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
5:30 PM
Sinclair Andrew (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
5:39 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
4:57 PM
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
12:14 PM
SCHULER JACK W (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
05/23/2023
5:47 PM
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2023
3:31 PM
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Soleno Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/18/2023
3:32 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D
05/15/2023
3:04 PM
SCHULER JACK W (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2023
4:28 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2023
4:28 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2023
3:30 PM
Abingworth LLP (Reporting)
Carlyle Genesis UK LLC (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Investment Management LLC (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
Soleno Therapeutics (Issuer)
TC Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2023
3:32 PM
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
Trump’s “Tax Free” Retirement Strategy (Ad)

Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.

Protect your retirement savings from the inevitable devaluation of the dollar…
05/09/2023
3:31 PM
Soleno Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2023
4:26 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SLNO) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners